The biggest drug manufacturer in the U.S., Sterling Drug Inc., last week published its first annual report since it has become one of the chief U.S. agencies for combating Nazi commercial interests in South America.
The report, showing gross sales of $53,448,000, revealed that net profits on both domestic and foreign business were down from $8,651,000 in 1941 to $7,086,000, a drop that could be explained by higher U.S. taxes. But the significant figure was profits from foreign subsidiaries other than England (mostly in Latin America), which dropped from $1,191,112 to $336,870.
The Headache. Behind those figures lies a complicated story...
To continue reading:
or
Log-In
